Phase 3b Study to Evaluate Skeletal Response to Eliglustat in Adult Patients Who Completed Phase 2 or Phase 3 Studies
Clinical trial NCT02536755 · COMPLETED
Trial details
- NCT number
- NCT02536755
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-27
- Primary completion
- 2021-06-24
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.